Loading clinical trials...
Loading clinical trials...
Consolidation PET-based and Donor-based After Salvage Therapy in Patients With Hodgkin Lymphoma in Relapse or Refractory
Conditions
Interventions
Patients with negative PET after salvage therapy
Patients with positive PET after salvage therapy
Locations
39
Italy
Istituto di Ematologia e Oncologia Medica, Policlinico S. Orsola
Bologna, Bologna, Italy
Unità funzionale di Ematologia AOU Careggi
Florence, Firenze, Italy
Dipartimento di Oncologia Medica ed Ematologia Istituto Clinico Humanitas
Rozzano, Milano, Italy
Ematologia Policlinico San Matteo
Pavia, Pavia, Italy
Ematologia Ospedale S. Maria delle Croci
Ravenna, RA, Italy
Div Ematologia A.O. Bianchi - Melacrino - Morelli
Reggio Calabria, RC, Italy
Start Date
May 1, 2009
Primary Completion Date
May 1, 2010
Completion Date
September 1, 2015
Last Updated
August 17, 2016
NCT06667687
NCT05618925
NCT05623982
NCT03314974
NCT06014073
NCT04586478
Lead Sponsor
Fondazione Italiana Linfomi - ETS
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions